Cargando…
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
Chagas disease is a vector-borne illness caused by the protozoan parasite Trypanosoma cruzi (T. cruzi). It poses a significant public health burden, particularly in the poorest regions of Latin America. Currently, there is no available vaccine, and chemotherapy has been the traditional treatment for...
Autores principales: | Porta, Exequiel O. J., Kalesh, Karunakaran, Steel, Patrick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416112/ https://www.ncbi.nlm.nih.gov/pubmed/37576826 http://dx.doi.org/10.3389/fphar.2023.1233253 |
Ejemplares similares
-
Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling
por: Porta, Exequiel O. J., et al.
Publicado: (2022) -
Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022) -
Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019) -
Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023) -
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)